Morning Movers 04/24: (ALIM) (ALGN) (CLS) Higher; (BIG) (NFLX) (HSTM) (CRDN) Lower

April 24, 2012 10:53 AM EDT Send to a Friend
Alimera Sciences, Inc., (Nasdaq: ALIM) 24.9% HIGHER; today announced the Austrian Agency for Health and Food Safety (Osterreichische Agentur fur Gesundheit und Ernahrungssicherheit, AGES) has granted marketing authorization to ILUVIENĀ® for the treatment of vision impairment associated with chronic diabetic macular edema (DME) considered insufficiently responsive to available therapies. Click here to see the full release.

Big Lots, Inc. (NYSE: BIG) 20.2% LOWER; now expect Q1 U.S. comparable store sales to be slightly negative compared to our prior guidance issued on March 2, 2012, which estimated a comparable store sales increase of 2% to 4%. U.S. comparable store sales were on plan through the first six weeks of the quarter; however, sales compared to plan began to slow in late March and trends have further softened as we moved through the month of April. From a merchandising perspective, furniture, hardlines, and seasonal, particularly lawn and garden, have been our best performing businesses; whereas, consumables and play n' wear, particularly electronics, are currently below expectations for the quarter. In terms of our recently acquired Canadian operations, based on results quarter-to-date, we anticipate retail sales for the first quarter of fiscal 2012 will be slightly above our guidance which estimated sales in the range of $25 to $30 million.

Align Technology, Inc. (NASDAQ: ALGN) 14.7% HIGHER; reported Q1 EPS of $0.27, $0.06 better than the analyst estimate of $0.21. Revenue for the quarter came in at $135.1 million versus the consensus estimate of $128.05 million. Align Technology, Inc. sees Q2 2012 EPS of $0.26-$0.28, versus the consensus of $0.24.

Netflix, Inc. (NASDAQ: NFLX) 13% LOWER; reported Q1 EPS of ($0.08), $0.19 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $870 million versus the consensus estimate of $868.07 million. Sees Q2 revs of $873-$895M versus the consensus of $897.35M. Sees Q2 loss of $0.10 - to EPS of $0.14, versus the consensus of a loss of $0.17.

HealthStream, Inc. (NASDAQ: HSTM) 13% LOWER; reported Q1 EPS of $0.05, $0.01 worse than the analyst estimate of $0.06. Revenue for the quarter came in at $23.7 million versus the consensus estimate of $22.75 million.

Ceradyne, Inc. (NASDAQ: CRDN) 13% LOWER; reported Q1 EPS of $0.16, $0.21 worse than the analyst estimate of $0.37. Revenue for the quarter came in at $106.3 million versus the consensus estimate of $120.08 million. Sees FY2012 EPS of $1.40-$1.65, versus prior guidance of $2.30-$2.65 and the consensus of $2.40. Sees FY2012 revenue of $540-$565 million, versus prior guidance of $590-$625 million and the consensus of $595.80 million.

Sanmina-SCI Corp (NASDAQ: SANM) 12.7% LOWER; reported Q2 EPS of $0.27, in-line with the analyst estimate of $0.27. Revenue for the quarter came in at $1.46 billion versus the consensus estimate of $1.51 billion. Sanmina-sci Corp sees Q3 2012 EPS of $0.26-$0.32, versus the consensus of $0.37.

Celestica, Inc. (NYSE: CLS) 11.2% HIGHER; reported Q1 EPS of $0.25, $0.04 better than the analyst estimate of $0.21. Revenue for the quarter came in at $1.8 billion versus the consensus estimate of $1.67 billion. Sees Q2 2012 EPS of $0.20-$0.26, versus the consensus of $0.25. Sees Q2 2012 revenue of $1.65-$1.75 billion, versus the consensus of $1.76 billion.

Symantec (Nasdaq: SYMC) 9.5% LOWER; reports preliminary Q4 sales of $1.68 billion and EPS of 38 cents. The company had previously guided Q4 sales to $1.72-$1.73 billion and EPS to 41-42 cents. The Street is currently looking for Q4 sales of $1.73 billion and EPS of 42 cents.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Special Reports

Related Entities

Morning Movers

Add Your Comment